Issues in the Conduct of Economic Evaluations of Pharmaceutical Products Michael F. Drummond Guest Editorial 30 November 2012 Pages: 405 - 411
Implementing Pharmacoeconomic Outcomes Management William F. McGhanBecky A. Briesacher Guest Editorial 30 November 2012 Pages: 412 - 416
A Comparative Analysis of the Pharmaceutical Market in Four European Countries Livio GarattiniFranco SalvioniSilvio Garattini Leading Article 30 November 2012 Pages: 417 - 423
Pharmaceutical Prices, Quantities and Innovation Naoki IkegamiWill MitchellJoan Penner-Hahn Review Article 30 November 2012 Pages: 424 - 433
Quality-of-Life Assessment of Adults with Growth Hormone Deficiency Stephen P. McKennaLynda C. Doward Review Article 30 November 2012 Pages: 434 - 441
Cost of Treatment and Prevention of Haemophilus influenzae Type b Disease Dennis A. Clements Review Article 30 November 2012 Pages: 442 - 452
Chemonucleolysis versus Surgical Discectomy for Sciatica Secondary to Lumbar Disc Herniation* Robert LaunoisBernadette HenryJean-Marie Goehrs Original Research Article 30 November 2012 Pages: 453 - 463
Economic Evaluation of Immunoprophylaxis in Children with Recurrent Ear, Nose and Throat Infections Kurt BanzDavid SchwickerAnne Marie Thomas Original Research Article 30 November 2012 Pages: 464 - 477
Expert Systems David NashPaul E. WindtAndrew M. Peterson Current Comment 30 November 2012 Pages: 478 - 479
Infection After Surgery for Gastrointestinal Cancer S. Ragnar Norrby Current Comment 30 November 2012 Pages: 483 - 484
Clarifying the Costs of Theophylline Toxicity Arthur S. Zbrozek Letter to the Editor 30 November 2012 Pages: 485 - 485